| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |